Vivesto AB (OTCPK:OASMY)
$ 0.0499 0 (0%) Market Cap: 8.95 Mil Enterprise Value: 3.84 Mil PE Ratio: 0 PB Ratio: 0.87 GF Score: 39/100

Q1 2021 Oasmia Pharmaceutical AB Earnings Call Transcript

Sep 09, 2020 / 08:00AM GMT
Release Date Price: $1.67
Operator

Welcome to the Oasmia Q1 Reports 2020-2021. With us today, we have CEO, Francois Martelet; and CFO, Michael Winklerfelt. (Operator Instructions)

I will now hand over to our speakers. Please go ahead.

Francois R. Martelet;publ;CEO
Oasmia Pharmaceutical AB

()-

Thank you. So Francois Martelet, CEO of Oasmia. I'm on the first slide. So today, I will give you an update following the presentation of our Q1 results earlier this morning. And obviously, I look forward to your questions that you will have at the end of this presentation.

So the forward-looking statement is on Slide 2. And on Slide 3, so here is the team basically leading the transformation of Oasmia. So we have recently added a lot of expertise to the company from the pharmaceutical and biotechnology sector with the appointment of Anders Harfstrand as Chairman of the company; and Birgit Stattin Norinder as a Board member, we have also on the Board Hege Hellstrom from our industry with a lot of experience as well.

So the Board is an experienced

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot